» Articles » PMID: 30483797

Carvedilol Suppresses Malignant Proliferation of Mammary Epithelial Cells Through Inhibition of the ROS‑mediated PI3K/AKT Signaling Pathway

Overview
Journal Oncol Rep
Specialty Oncology
Date 2018 Nov 29
PMID 30483797
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Reactive oxygen species (ROS) cause oncogenic mutations through direct interaction with DNA. Carvedilol (CAR) exhibits antioxidative activity, and pre‑clinical studies have identified that CAR may prevent malignant transformation in certain carcinogenic models. This suggests that CAR may be a potential agent in cancer prevention. In the present study, non‑cancerous MCF‑10A cells were used as a model to investigate the chemopreventive effect of CAR on benzo(a)pyrene (BaP)‑induced cellular carcinogenesis. It was identified that CAR had the ability to eliminate BaP‑induced ROS production and subsequent DNA damage. CAR/BaP activated the ROS‑mediated phosphoinositide 3‑kinase (PI3K)/protein kinase B (AKT)Thr308 signaling pathway, whereas the effectors of the PI3K/AKT signaling pathway, murine double minute 2 (MDM2) and p53Ser15, served important functions in the BaP/CAR‑mediated MCF10A cellular transformation. The results of the present study indicated that CAR may be a novel chemopreventive agent, notably in the prevention of estrogen receptor‑negative breast cancer. The antioxidant effects of CAR may contribute to its chemopreventive activity.

Citing Articles

Investigating Carvedilol's Repurposing for the Treatment of Non-Small Cell Lung Cancer via Aldehyde Dehydrogenase Activity Modulation in the Presence of β-Adrenergic Agonists.

Ikhmais B, Hammad A, Abusara O, Hamadneh L, Abumansour H, Abdallah Q Curr Issues Mol Biol. 2023; 45(10):7996-8012.

PMID: 37886948 PMC: 10605277. DOI: 10.3390/cimb45100505.


Does each Component of Reactive Oxygen Species have a Dual Role in the Tumor Microenvironment?.

Hao S, Cai D, Gou S, Li Y, Liu L, Tang X Curr Med Chem. 2023; 31(31):4958-4986.

PMID: 37469162 PMC: 11340293. DOI: 10.2174/0929867331666230719142202.


Dynamic changes of DNA methylation induced by benzo(a)pyrene in cancer.

Wang H, Liu B, Chen H, Xu P, Xue H, Yuan J Genes Environ. 2023; 45(1):21.

PMID: 37391844 PMC: 10314634. DOI: 10.1186/s41021-023-00278-1.


and study on the effect of carvedilol and sorafenib alone and in combination on the growth and inflammatory response of melanoma cells.

Wawszczyk J, Wolan R, Smolik S, Kapral M Saudi Pharm J. 2023; 31(7):1306-1316.

PMID: 37323921 PMC: 10265481. DOI: 10.1016/j.jsps.2023.05.020.


The β-Blocker Carvedilol Prevents Benzo(a)pyrene-Induced Lung Toxicity, Inflammation and Carcinogenesis.

Shahid A, Chen M, Lin C, Andresen B, Parsa C, Orlando R Cancers (Basel). 2023; 15(3).

PMID: 36765542 PMC: 9913110. DOI: 10.3390/cancers15030583.


References
1.
Mayo L, Donner D . A phosphatidylinositol 3-kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus. Proc Natl Acad Sci U S A. 2001; 98(20):11598-603. PMC: 58775. DOI: 10.1073/pnas.181181198. View

2.
Zhou B, Liao Y, Xia W, Zou Y, Spohn B, Hung M . HER-2/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation. Nat Cell Biol. 2001; 3(11):973-82. DOI: 10.1038/ncb1101-973. View

3.
Cooke M, Evans M, Dizdaroglu M, Lunec J . Oxidative DNA damage: mechanisms, mutation, and disease. FASEB J. 2003; 17(10):1195-214. DOI: 10.1096/fj.02-0752rev. View

4.
Yue T, Cheng H, Lysko P, McKenna P, Feuerstein R, Gu J . Carvedilol, a new vasodilator and beta adrenoceptor antagonist, is an antioxidant and free radical scavenger. J Pharmacol Exp Ther. 1992; 263(1):92-8. View

5.
Oliveira P, Goncalves L, Monteiro P, Providencia L, Moreno A . Are the antioxidant properties of carvedilol important for the protection of cardiac mitochondria?. Curr Vasc Pharmacol. 2005; 3(2):147-58. DOI: 10.2174/1570161053586903. View